NRNP 6665 Week 11 Final Exam (Latest 2025 / 2026) Qs & Ans: Most Comprehensive to Pass the Exam, 100% Verified (UPDATED)

NRNP 6665 Week 11 Final Exam (Latest ) Qs & Ans: Most Comprehensive
to Pass the Exam, 100% Verified (UPDATED)

NRNP 6665 Week 11 Final Exam (Latest 2025 /
2026) Qs & Ans: Most Comprehensive to Pass the
Exam, 100% Verified (UPDATED)



Multiple-Choice Questions
Question 1: The Confusion Assessment Method Instrument (CAM) is used to assess
which disorder?

A. Dementia
B. Delirium
C. Schizophrenia
D. Depression

Correct Answer: B. Delirium
Rationale: The CAM is a standardized tool designed to identify delirium,
characterized by acute onset, fluctuating cognition, and altered conscious-
ness. PMHNPs use it for rapid bedside assessment, distinguishing delirium
from dementia, which has a gradual onset. Schizophrenia and depression
are unrelated to CAM’s purpose.

Question 2: Which of the following is a hallmark symptom of pyromania?

A. Recurrent fire-setting for financial gain
B. Deliberate fire-setting with fascination or pleasure
C. Fire-setting due to hallucinations
D. Accidental fire-setting during substance use

Correct Answer: B. Deliberate fire-setting with fascination or
pleasure
Rationale: Pyromania, per DSM-5, involves recurrent, deliberate fire-
setting driven by fascination or pleasure, not external motives like financial
gain or psychosis. PMHNPs assess for impulse control disorders, ruling out
substance-induced or psychotic causes.

Question 3: A patient with end-stage renal disease and schizophrenia represents which
psychosomatic medicine issue?

A. Psychiatric symptoms secondary to medical condition
B. Co-occurring medical and psychiatric conditions
C. Psychiatric complications of medical treatment
D. Medical complications of psychiatric treatment



1

,NRNP 6665 Week 11 Final Exam (Latest ) Qs & Ans: Most Comprehensive
to Pass the Exam, 100% Verified (UPDATED)

Correct Answer: B. Co-occurring medical and psychiatric condi-
tions
Rationale: Schizophrenia and end-stage renal disease are independent but
co-occurring conditions. PMHNPs must manage both, considering med-
ication interactions (e.g., antipsychotics and renal function) and holistic
care planning.[](https://www.studocu.com/en-us/document/university-of-
north-texas-health-science-center/swift-river/nrnp-6665-final-exam-with-100-
verified-solutions-2023-2024/43812552)

Question 4: Which medication is NOT typically used for Parkinson’s disease dementia
or psychosis?

A. Rivastigmine
B. Donepezil
C. Pimavanserin
D. Memantine

Correct Answer: D. Memantine
Rationale: Rivastigmine and donepezil (cholinesterase inhibitors) treat
Parkinson’s dementia, while pimavanserin targets psychosis. Memantine,
an NMDA receptor antagonist, is used for Alzheimer’s dementia, not Parkin-
son’s, due to differing neurochemical profiles.[](https://www.studocu.com/en-
us/document/university-of-north-texas-health-science-center/swift-river/nrnp-
6665-final-exam-with-100-verified-solutions-2023-2024/43812552)

Question 5: A patient with a history of trauma presents with inability to recall the
event but no physiological cause. This is consistent with:

A. Dissociative amnesia
B. Somatic symptom disorder
C. Post-traumatic stress disorder
D. Conversion disorder

Correct Answer: A. Dissociative amnesia
Rationale: Dissociative amnesia involves memory loss for specific trau-
matic events without a physiological basis, per DSM-5. PMHNPs dif-
ferentiate it from PTSD (broader symptoms), somatic symptom disorder
(physical focus), and conversion disorder (motor/sensory deficits).

Question 6: Which brain region is most associated with deficits in attention and multi-
step command completion?

A. Temporal lobe
B. Prefrontal cortex
C. Occipital lobe
D. Cerebellum



2

, NRNP 6665 Week 11 Final Exam (Latest ) Qs & Ans: Most Comprehensive
to Pass the Exam, 100% Verified (UPDATED)

Correct Answer: B. Prefrontal cortex
Rationale: The prefrontal cortex governs executive functions, includ-
ing attention and task sequencing. PMHNPs assess this in ADHD or
frontal lobe injuries, using tools like the Stroop test to guide diagnosis and
treatment.[](https://www.docsity.com/en/docs/nrnp-6665-final-exam-135-
questions-answers-walden-university-new-2022-2023/9337059/)

Question 7: Depression secondary to interferon treatment is an example of:

A. Psychiatric symptoms secondary to medical condition
B. Co-occurring medical and psychiatric conditions
C. Psychiatric symptoms as a reaction to medical treatment
D. Medical complications of psychiatric treatment

Correct Answer: C. Psychiatric symptoms as a reaction to med-
ical treatment
Rationale: Interferon commonly induces depression as a side effect. PMH-
NPs monitor for this, adjusting treatment (e.g., SSRIs) while coordinating
with medical teams to manage the underlying condition.[](https://www.studocu.com/en-
us/document/university-of-north-texas-health-science-center/swift-river/nrnp-
6665-final-exam-with-100-verified-solutions-2023-2024/43812552)

Question 8: Which is NOT consistent with depersonalization/derealization disorder
epidemiology?

A. 1–2% lifetime prevalence
B. Equal prevalence in men and women
C. Common in seizure or migraine patients
D. Always pathological

Correct Answer: D. Always pathological
Rationale: Depersonalization/derealization can occur in non-pathological
contexts (e.g., stress) or with seizures/migraines. Its lifetime prevalence is
1–2%, with no gender disparity. PMHNPs assess context to avoid over-
diagnosing.[](https://www.docsity.com/en/docs/nrnp-6665-final-exam-135-
questions-answers-walden-university-new-2022-2023/9337059/)

Question 9: Which of the following is a risk factor for sexual assault?

A. Religious affiliation
B. Substance use
C. Male gender
D. Older age

Correct Answer: B. Substance use
Rationale: Substance use increases vulnerability to sexual assault by im-
pairing judgment and situational awareness. PMHNPs screen for substance
use in trauma assessments, as religion, male gender, and older age are not

3